摘要
目的探讨静脉滴注垂体后叶素联合普鲁卡因治疗肺结核咯血的疗效和不良反应。方法对我科收治的108例肺结核咯血患者随机分为垂体后叶素联合普鲁卡因组(观察组)及单用垂体后叶素组(对照组),对比两组的疗效及咯血停止时间和不良反应。结果观察组疗效明显优于对照组,两组总有效率、咯血停止时间、不良反应比较具有显著差异(P<0.01)。结论垂体叶素联合普鲁卡因治疗肺结核咯血能缩短出血时间、减少出血、提高疗效,又能相互抵消各自的不良反应,效果满意,值得临床推广使用。
Objective Discussion on intravenous infusion Pituitary--Procaine treatment massive hemoptysis tuberculosis the efficacy and side effects reaction. Methods 108 cases of massive hemoptysis tuberculosis patients were randomized into the observation group and control group, compared the efficacy and hemoptysis stopped times and side effects. Results The observation group was significantly better than that of the control group, showed that the overall efficiency hemoptysis stop time and side effects significantly （P〈0.01）. Conclusion This observe can shorten the bleeding time of massive hemoptysis tuberculosis and reduce bleeding, the efficacy, but also offset their own side effects. The result is worthy of clinical application.
出处
《临床医学工程》
2008年第12期16-17,共2页
Clinical Medicine & Engineering
关键词
静脉滴注
垂体后叶素
普鲁卡因
肺结核
咯血
Intravenous infusion
Pituitary
Procaine
Tuberculosis
Hemoptysis
